Statements (57)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:national_football_team
|
| gptkbp:bfsLayer |
7
|
| gptkbp:bfsParent |
gptkb:Late-onset_Alzheimer's_Disease
|
| gptkbp:affects |
lipid metabolism
|
| gptkbp:analyzes |
lifestyle interventions
preventive strategies biomarker research |
| gptkbp:associated_with |
gptkb:psychologist
|
| gptkbp:can_be |
individuals with higher Alzheimer's risk
|
| gptkbp:descendant |
gptkb:Person
|
| gptkbp:examines |
clinical studies
population studies longitudinal studies aging research |
| gptkbp:has_impact_on |
gptkb:architect
|
| gptkbp:has_influence_on |
response to treatment in Alzheimer's patients
|
| https://www.w3.org/2000/01/rdf-schema#label |
APOE ε4 allele
|
| gptkbp:influences |
neurodegeneration
|
| gptkbp:investment |
cognitive decline
|
| gptkbp:is_a |
gptkb:physicist
|
| gptkbp:is_associated_with |
gptkb:late-onset_Alzheimer's_disease
neuroinflammation behavioral changes increased oxidative stress decreased cognitive reserve increased amyloid plaque deposition increased risk of dementia vascular contributions to dementia |
| gptkbp:is_considered |
clinical trials
family history evaluations risk assessment for Alzheimer's |
| gptkbp:is_considered_as |
a risk factor
|
| gptkbp:is_found_in |
human genome
various populations genetic databases genetic risk assessments clinical guidelines for Alzheimer's disease |
| gptkbp:is_linked_to |
gptkb:hospital
cognitive impairment memory impairment increased inflammation decreased brain volume impaired neurogenesis increased tau pathology reduced synaptic function |
| gptkbp:is_often_used_in |
older adults
|
| gptkbp:is_part_of |
gptkb:APOE_gene
Alzheimer's research genetic counseling guidelines genetic counseling discussions genetic predisposition studies |
| gptkbp:is_recognized_by |
genetic testing
|
| gptkbp:is_related_to |
cholesterol levels
|
| gptkbp:is_studied_in |
therapeutic interventions
genetic epidemiology therapeutic targets neuropsychological assessments |